Mark T Tripputi
Overview
Explore the profile of Mark T Tripputi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cherrington A, Tripputi M, Younes N, Herman W, Katona A, Groessl E, et al.
Diabetes Care
. 2024 Jan;
47(4):603-609.
PMID: 38190625
Objective: Diabetes is associated with reduced health-related quality of life (HRQoL). Information on the relationship between HRQoL and glucose-lowering medications in recently diagnosed type 2 diabetes (T2D) is limited. We...
2.
Utzschneider K, Tripputi M, Kozedub A, Barengolts E, Caprio S, Cree-Green M, et al.
Diabetes Res Clin Pract
. 2021 Jul;
178:108948.
PMID: 34274407
Aims: To compare OGTT-derived estimates of β-cell function between youth and adults with impaired glucose tolerance (IGT) or recently diagnosed type 2 diabetes after treatment discontinuation in RISE. Methods: Youth...
3.
Goldberg R, Tripputi M, Boyko E, Budoff M, Chen Z, Clark J, et al.
J Clin Endocrinol Metab
. 2021 Mar;
106(11):e4746-e4765.
PMID: 33705543
Context: There is little information about fatty liver in prediabetes as it transitions to early diabetes. Objective: This study is aimed at evaluating the prevalence and determinants of fatty liver...
4.
Walker E, Gonzalez J, Tripputi M, Dagogo-Jack S, Matulik M, Montez M, et al.
BMJ Open Diabetes Res Care
. 2020 Oct;
8(1).
PMID: 33023898
Introduction: To investigate long-term metformin adherence in the Diabetes Prevention Program Outcomes Study (DPPOS) by examining: (1) predictors of long-term adherence to study metformin and (2) whether metformin adherence was...
5.
Utzschneider K, Tripputi M, Kozedub A, Mather K, Nadeau K, Edelstein S, et al.
Pediatr Diabetes
. 2020 Sep;
21(8):1421-1429.
PMID: 32902875
Objective: Glycemic control deteriorates more rapidly in youth vs adults. We compared model-derived measures of β-cell function between youth and adults with either impaired glucose tolerance (IGT) or type 2...
6.
Dreskin S, Tripputi M, Aubrey M, Mustafa S, Atkins D, Leo H, et al.
Clin Immunol
. 2010 Sep;
137(3):366-73.
PMID: 20850383
We enrolled 53 peanut-allergic subjects and 64 peanut-tolerant full siblings, measured peanut-specific IgG and IgE, determined HLA class II at high resolution, and analyzed DRB1 alleles by supertypes. Peanut-specific IgG...
7.
Ruo B, Tripputi M, Hsue P, Saigo M, Ouyang P, Waters D
Am J Cardiol
. 2005 Aug;
96(3):335-8.
PMID: 16054453
We performed a cohort study of 392 postmenopausal women who had coronary disease to assess whether baseline serum endothelin-1 level predicts angiographic disease progression, nonfatal myocardial infarction, or death. Angiographic...